These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
106 related items for PubMed ID: 8676802
1. Effectiveness of dietary protein augmentation associated with angiotensin-converting enzyme inhibition in the management of the nephrotic syndrome. Garini G, Mazzi A, Allegri L, Buzio C, Borghetti A. Miner Electrolyte Metab; 1996; 22(1-3):123-7. PubMed ID: 8676802 [Abstract] [Full Text] [Related]
2. [Effect of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome]. Tesar V, Zima T, Jirsa M, Crkovská J, Stípek S, Vernerová Z, Seráková M. Cas Lek Cesk; 1999 Oct 20; 138(18):560-4. PubMed ID: 10596472 [Abstract] [Full Text] [Related]
3. Effect of dietary protein intake and angiotensin converting enzyme inhibition in Heymann nephritis. Kaysen GA, Davies RW, Hutchison FN. Kidney Int Suppl; 1989 Nov 20; 27():S154-62. PubMed ID: 2561514 [Abstract] [Full Text] [Related]
4. Effect of dietary protein restriction and angiotensin converting enzyme inhibition on protein metabolism in the nephrotic syndrome. Don BR, Wada L, Kaysen GA, Schambelan M. Kidney Int Suppl; 1989 Nov 20; 27():S163-7. PubMed ID: 2561515 [No Abstract] [Full Text] [Related]
5. Reduction in proteinuria attenuates hyperlipidemia in the nephrotic syndrome. Kaysen GA, Davies RW. J Am Soc Nephrol; 1990 Nov 20; 1(5 Suppl 2):S75-9. PubMed ID: 16989070 [Abstract] [Full Text] [Related]
6. Comparative study of angiotensin converting enzyme inhibitor and calcium channel blocker in the treatment of steroid-resistant idiopathic nephrotic syndrome. Kumar NS, Singh AK, Mishra RN, Prakash J. J Assoc Physicians India; 2004 Jun 20; 52():454-8. PubMed ID: 15645954 [Abstract] [Full Text] [Related]
7. Efficacy of enalapril in the treatment of steroid resistant idiopathic nephrotic syndrome. Prasher PK, Varma PP, Baliga KV. J Assoc Physicians India; 1999 Feb 20; 47(2):180-2. PubMed ID: 10999084 [Abstract] [Full Text] [Related]
8. Enalapril: antiproteinuric effect in children with nephrotic syndrome. Lama G, Luongo I, Piscitelli A, Salsano ME. Clin Nephrol; 2000 Jun 20; 53(6):432-6. PubMed ID: 10879662 [Abstract] [Full Text] [Related]
9. Effects of angiotensin-converting enzyme inhibitor and steroid therapy on proteinuria in FSGS: a retrospective study in a single clinic. Stiles KP, Abbott KC, Welch PG, Yuan CM. Clin Nephrol; 2001 Aug 20; 56(2):89-95. PubMed ID: 11522100 [Abstract] [Full Text] [Related]
10. Effect of a high protein diet in patients with the nephrotic syndrome. Mansy H, Goodship TH, Tapson JS, Hartley GH, Keavey P, Wilkinson R. Clin Sci (Lond); 1989 Oct 20; 77(4):445-51. PubMed ID: 2805603 [Abstract] [Full Text] [Related]
11. Influence of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome. Tesar V, Zima T, Jirsa M, Crkovská J, Stípek S, Vernerová Z, Seráková M. Med Sci Monit; 2002 Feb 20; 8(2):BR69-74. PubMed ID: 11859270 [Abstract] [Full Text] [Related]
12. Angiotensin converting enzyme insertion/deletion polymorphism and short-term renal response to ACE inhibition: role of sodium status. van der Kleij FG, Schmidt A, Navis GJ, Haas M, Yilmaz N, de Jong PE, Mayer G, de Zeeuw D. Kidney Int Suppl; 1997 Dec 20; 63():S23-6. PubMed ID: 9407415 [Abstract] [Full Text] [Related]
13. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study. Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z, Amlodipine Versus Enalapril in Renal failure (AVER) Study Group. Clin Ther; 2008 Mar 20; 30(3):482-98. PubMed ID: 18405787 [Abstract] [Full Text] [Related]
14. Nail-patella syndrome, infantile nephrotic syndrome: complete remission with antiproteinuric treatment. Proesmans W, Van Dyck M, Devriendt K. Nephrol Dial Transplant; 2009 Apr 20; 24(4):1335-8. PubMed ID: 19147669 [Abstract] [Full Text] [Related]
15. [Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline]. Renke M, Rutkowski P, Tylicki L, Zietkiewicz M, Larczyński W, Rutkowski B. Przegl Lek; 2008 Apr 20; 65(6):312-4. PubMed ID: 18853664 [Abstract] [Full Text] [Related]
16. [Protein metabolism during nephrotic syndrome. Experimental and clinical influence of dietary protein intake]. Combe C, Aparicio M. Nephrologie; 1993 Apr 20; 14(4):171-5. PubMed ID: 8232711 [Abstract] [Full Text] [Related]
17. The effect of enalapril on nephrotic proteinuria and determination of serum angiotensin-converting enzyme before and after treatment. Bianchini G, Letizia C, Domenici A, Scavo D. Drugs Exp Clin Res; 1991 Apr 20; 17(5):263-9. PubMed ID: 1661665 [Abstract] [Full Text] [Related]
18. Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis. Jennings DL, Kalus JS, Coleman CI, Manierski C, Yee J. Diabet Med; 2007 May 20; 24(5):486-93. PubMed ID: 17367311 [Abstract] [Full Text] [Related]
19. Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis. Tylicki L, Renke M, Rutkowski P, Rutkowski B, Lysiak-Szydłowska W. Med Sci Monit; 2005 Apr 20; 11(4):PI31-7. PubMed ID: 15795705 [Abstract] [Full Text] [Related]
20. Distinct time courses of renal protective action of angiotensin receptor antagonists and ACE inhibitors in chronic renal disease. Matsuda H, Hayashi K, Saruta T. J Hum Hypertens; 2003 Apr 20; 17(4):271-6. PubMed ID: 12692572 [Abstract] [Full Text] [Related] Page: [Next] [New Search]